EPHB2 and cancer: As phosphoinositide-3-kinase–protein kinase B/AKT (PI3K-PKB/AKT) and mitogen-activated kinase (MAPK) signaling pathways are often involved in cancer cell proliferation [24], we examined the impact of EPHB3 expression on the activation of the AKT and ERK proteins.